Industry Insights: Medcomms. A round up of MedComms news and insights

Industry Insights: MedComms 11th July

Industry Insights: MedComms 11th July

  • Reading time:2 mins read

Industry Insights MedComms: 11/07/25

This week’s post discusses three recent insights regarding regulatory writing tips, prompts for generative artificial intelligence (genAI) and careers in medical communications.

 

Writing about medical devices as a regulatory writer

In a recent interview posted by NetworkPharma.tv, Geneviève Laumen, freelance medical writer with a background in neuroscience and biology, shared her perspective on regulatory writing about medical devices. Unlike pharmaceutical writing, which often centres around clinical trial data, writing about medical devices requires translating highly technical material into regulatory-compliant content. According to Laumen, communicating with engineers and device developers can be as important as understanding the regulatory landscape. Laumen also offered tips on finding clients and integrating AI tools into writing.

Link to the interview 

 

The correct way of prompting GenAI in MedComms

The latest episode of In Plain Cite, a podcast hosted by Rob Matheis, offers a thoughtful take on how we interact with generative AI (genAI). Conor Grennan, Chief AI Architect at NYU Stern and CEO of AI Mindset, discussed with Matheis how prompting is moving to a conversational process. The episode encouraged writers to approach prompting as they would a human colleague: adjusting the tone, asking clear questions and expressing intent. According to Grennan, the most effective AI interactions come from curious and flexible users. The discussion emphasised, however, that AI remains a support tool that requires human oversight.

Link to podcast 

 

Finding your place in #MedComms 

A recent article from the International Society for Medical Publication Professionals (ISMPP) offers a short and practical guide for everyone looking at career choices in medical communications. The piece highlighted how different paths, such as work in agencies, work in pharma companies or freelance work, bring different challenges. Agency life is client-centred; it comes with a broad range of therapeutic areas and quick deadlines. Roles in a pharma company are usually well-defined and provide opportunities to collaborate across corporate departments. For those leaning toward autonomy and flexibility, freelancing offers the freedom to choose projects and manage your own time. Thus, it demands self-discipline and, at times, a tolerance for uncertainty. According to the article, there is no ‘best’ path. Instead, writers are encouraged to reflect on their working style, values and goals when thinking where they can thrive. 

Link to full article

 

Want to get in touch? Contact us today at https://elion.nz/get-in-touch/.

Elion Medical Communications